EBOS Group (ASX:EBO) Insider Acquires A$108,562.20 in Stock

EBOS Group Limited (ASX:EBO) insider Matthew Muscio purchased 3,800 shares of the business’s stock in a transaction on Monday, November 10th. The shares were bought at an average cost of A$28.57 per share, with a total value of A$108,562.20.

EBOS Group Price Performance

The stock has a market cap of $8.20 billion, a P/E ratio of 27.51 and a beta of 0.26. The company has a quick ratio of 0.76, a current ratio of 0.95 and a debt-to-equity ratio of 66.89.

EBOS Group Cuts Dividend

The firm also recently declared a Final dividend, which was paid on Tuesday, September 23rd. Investors of record on Tuesday, September 23rd were issued a $0.492 dividend. The ex-dividend date of this dividend was Wednesday, September 3rd. This represents a dividend yield of 168.0%. EBOS Group’s dividend payout ratio (DPR) is presently 72.14%.

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.